Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

"Vaxxed: From Cover-Up to Catastrophe" the Most Controversial Film in America Launches a Nationwide Bus Tour on August 6th

Film distribution company Cinema Libre Studio announces the team behind America's most controversial documentary, "Vaxxed: From Cover-Up to Catastrophe," will hit the road on a nationwide bus tour traveling to the home districts of members of the United States House Committee on Oversight & Government Reform, the entity responsible for subpoenaing the Centers for Disease Control and Prevention (CDC) whistleblower, Dr. William Thompson, a subject at the heart of the film.


News provided by

Cinema Libre Studio

Jul 27, 2016, 09:44 ET

Share this article

Share toX

Share this article

Share toX

LOS ANGELES, July 27, 2016 /PRNewswire/ -- Following a notable theatrical U.S. and Canadian release, the team behind America's most controversial film, "Vaxxed: From Cover-Up to Catastrophe," will hit the road on a nationwide bus tour starting August 6th. The Vaxxed filmmakers will be traveling to the home districts of several members of the United States House Committee on Oversight & Government Reform, the entity responsible for subpoenaing the Centers for Disease Control and Prevention (CDC) whistleblower, Dr. William Thompson, a subject at the heart of the film.

Continue Reading

Photo - http://photos.prnewswire.com/prnh/20160727/393625

Dubbed the "Vaxxed Nation Tour", the retrofitted bus will act as a mobile TV network, with filmmakers Del Bigtree and Polly Tommey broadcasting the stories of the vaccine injured families they meet along the way, as well as local interviews and news about the most current vaccine mandates across the country. In conjunction with its ongoing theatrical release, "Vaxxed" is now scheduled to be screened in almost 600 cinemas as part of a theatrical-on-demand program that distributor Cinema Libre Studio has forged with GATHR ®. The bus will be stopping in many of these cities for filmmaker Q&As along the way.

Director Andrew Wakefield and producer Polly Tommey appeared In April on Fox and Friends, during which they underscored how, contrary to some reports, the film is not anti-vaccine. "Vaxxed" producer Del Bigtree recently had a publicly-taped conversation with California Senator Ben Allen, the staunchly pro-vaccine co-author of SB277, California's new law mandating that every child be vaccinated before attending school. Senator Allen said on camera, "I watched "Vaxxed," and it's not an anti-vaccine film." Rather, the film reveals previously unreleased CDC data showing a statistical association between the introduction of MMR and the phenomenal spike in the number of autism cases in the U.S. Twenty years ago, 1 in 10,000 children were autistic and today the shocking figure is 1 in 68 children.

"Vaxxed" captured international headlines when it was pulled from the already-announced line-up of the Tribeca Film Festival under pressure from festival sponsors. Two weeks later, Robert De Niro, a festival co-founder, went on national network television (NBC's "Today Show") and renounced the "de-selection" of the film saying, "I think the movie is something that people should see. There was definitely something to that movie..." He goes on to say, "There's a lot of information about things that are happening with the CDC, the pharmaceutical companies. I, as a parent of a child who has autism, I'm concerned. And I want to know the truth."

Following its unprecedented "de-selection," "Vaxxed" has surprised many with a comprehensive U.S. and Canadian theatrical run reaching 65 cities and 29 states. Immediately following the de-selection, distributor Cinema Libre Studio launched the film on a nationwide theatrical release with 4 ½ days of preparation, premiering April 1st at the prestigious Angelika Film Center in NYC, where it achieved the highest single screen box office gross for a documentary this year.

"Vaxxed" investigates how the Centers for Disease Control and Prevention (CDC) concealed and destroyed data on their 2004 study that showed a link between the MMR (measles, mumps and rubella) vaccine and autism. The information was revealed by a whistle-blower inside the CDC, senior research scientist William Thompson.

In July of 2015, Congressman William Posey (R-FL) took to the floor to inform Congress of Dr. Thompson's whistleblower testimony that details significant data that he and his co-authors omitted and destroyed to avoid reporting a possible link between the MMR vaccine and autism. https://www.c-span.org/video/?c4546421/rep-bill-posey-calling-investigation-cdcs-mmr-reasearch-fraud

The "Vaxxed" team of filmmakers, editors and photographers will start the two-month tour on August 6 in Oakland, CA with the objective of stopping in Congressional districts that have members who sit on the United States House Committee of Oversight & Government Reform. With these targeted screening events and Q&As in these key Congressional districts, the "Vaxxed" bus tour hopes to progress the subpoenaing of Dr. Thompson by the Committee. Says producer Del Bigtree, "It is our intention to visit as many of the 29 states where the Congressional Members of the Oversight Committee on Government Reform live and to engage them and their staff in a productive conversation about vaccine safety and the confessions of scientific fraud by Dr. William Thompson, the 'CDC  Whistleblower'."

The film is produced by Polly Tommey of the Autism Media Channel and Del Bigtree, formerly a producer of the hit show "The Doctors." The film is directed by Dr. Andrew Wakefield, an academic gastroenterologist who has published over 140 peer-reviewed scientific publications and spoken internationally on autism and vaccines. Dr. Wakefield and Dr. John Walker-Smith, one of the world's leading pediatric gastroenterologists, were the first to discover that vaccines caused gut problems that could lead to autism (1998). They, along with 11 other authors, published their results in The Lancet, a British medical journal, in February 1998.

For this, the British General Medical Council (GMC), acting to protect the government from coming under fire for the potential damage caused by vaccines, decided that Dr. Wakefield and his co-author had acted unethically, and they lost their medical licenses. Both Dr. Wakefield and Professor Walker-Smith appealed the GMC ruling in the English High Court. Professor Walker-Smith's professional insurance paid for his appeal. Dr. Wakefield's insurance carrier would not, therefore Dr. Wakefield was not able to continue his appeal. After reviewing the original findings, Justice Mitting found that the GMC's conclusions were "based on inadequate and superficial reasoning" and that "the finding of serious professional misconduct and the sanction of erasure are both quashed." Dr. Walker-Smith's license was completely reinstated, and all charges against him were dismissed.

Ninety percent of the charges against Walker-Smith were the same charges as those against Dr. Wakefield, so had he been able to appeal, the verdict would have applied to Dr. Wakefield also. The Lancet paper should have been reinstated, and yet The Lancet editor refused to do that in order to protect his reputation and his job. Justice Mitting's judicial decision marked a long awaited turning point in a decades long campaign to discredit the 1998 Lancet article and Dr. Wakefield in particular.

In large part, the film's success has been fueled by local groups of parents who believe their children have been injured by vaccines and who have organized tremendous grassroots efforts to help bring the film to their cities. With over 600 screenings getting up in less than a month, "Vaxxed" is on track to become the largest crowd-sourced theatrical campaign of all time.

"Vaxxed" has been endorsed by leading autism and vaccine safety organizations including: Autism Action Network, Autism is Medical (AIM), AutismOne, California Coalition for Vaccine Choice, Canary Party, Generation Rescue, Health Choice Health First, Health Freedom Coalition, Million Mamma's Movement, Moms in Charge, National Vaccine Information Center, Our Kids, Our Choice, SafeMinds, Thinking Mom's Revolution, A Voice for Choice and Vaccine Injury Awareness League.

 The Vaxxed movement is specifically asking for:

[1] That Congress subpoena Dr. William Thompson and investigate the CDC fraud.

[2] That Congress repeal the 1986 National Childhood Vaccine Injury Act and hold manufacturers liable for injury caused by their vaccines.

[3] That the single measles, mumps, and rubella vaccine be made available immediately.

[4] That all vaccines be classified as pharmaceutical drugs and tested accordingly.

For information on the Vaxxed Nation Tour schedule of RV locations and screenings: http://vaxxedthemovie.com/vaxxed-nation-tour/

Follow @Vaxxedthemovie #vaxxed

For more information, please contact:

Jamie Coker Robertson, JCR Consulting, 310-804-1408, [email protected]

Jennifer Lopez, JLPR, 310-864-8633, [email protected]

Related Images

image1.jpg

image2.jpg

Related Links

Vaxxed Official Website

Cinema Libre Studio

Related Video

https://vimeo.com/159566038

This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com 

SOURCE Cinema Libre Studio

Related Links

http://www.cinemalibrestudio.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.